Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


August 02, 2015 9:45 PM ET

Biotechnology

Company Overview of OvaScience, Inc.

Company Overview

OvaScience, Inc., a life science company, engages in the discovery, development, and commercialization of new treatments for infertility. The company’s patented technology is based on the discovery of egg precursor (EggPC) cells, which are immature egg cells found in the protective outer layer of a woman's own ovaries. It is developing and commercializing various fertility treatment options designed to enhance egg health and revolutionize in vitro fertilization (IVF) comprising AUGMENT to improve the energy and health of the woman’s eggs by using mitochondria from a woman's EggPC cells; OvaPrime treatment for boosting a woman's egg reserve by transferring the EggPCs from woman's own ovaries;...

215 First Street

Suite 240

Cambridge, MA 02142

United States

Founded in 2011

52 Employees

Phone:

617-500-2802

Key Executives for OvaScience, Inc.

Co-Founder, Chief Executive Officer and Director
Age: 39
President and Chief Scientific Officer
Total Annual Compensation: $644.0K
Chief Commercial Officer
Age: 49
Total Annual Compensation: $21.1K
Compensation as of Fiscal Year 2014.

OvaScience, Inc. Key Developments

OvaScience Appoints Revi Mehrotra as the Chief Corporate Development Officer

OvaScience has named Revi Mehrotra as the chief corporate development officer. Mehrotra was recently global head of biotechnology equity research at Credit Suisse.

OvaScience, Inc. Appoints John Eisel as Executive Vice President of Global Site Operations, and Gabriel M. Cohn as Head of Medical Affairs and Translational Medicine

OvaScienceSM announced two new positions that support OvaScience™s expanding international operations. John Eisel has joined the Company as Executive Vice President of Global Site Operations, and Gabriel M. Cohn, M.D., has joined as Head of Medical Affairs and Translational Medicine. Mr. Eisel joins from InnerWorkings LLC, where he served as Chief Operating Officer since 2011. Prior to that, he was Divisional Vice President of Strategic Operations, Pharmacy Services for Walgreens. He also held roles of increasing responsibility at McKinsey & Company, including serving as Associate Principal. Mr. Eisel began his career at PricewaterhouseCoopers, serving as a Senior Associate in Financial Advisory Services. Dr. Cohn is a Board-certified OB/GYN and Clinical Geneticist who previously served as the Chief of the Division of Clinical and Reproductive Genetics Department at Baystate Medical Center and the Director of Reproductive Genetics, Division of Maternal Fetal Medicine at SUNY Health Science Center (HSC) at Syracuse. Dr. Cohn joins OvaScience from Shire, where he held roles that included Medical Director and Interim Medical Lead for the Gaucher Disease Franchise and the Senior Medical Director of Clinical Sciences.

OvaScience Appoints John P. Howe to the Board of Directors

OvaScience announced the appointment of John P. Howe, III, M.D., former President and Chief Executive Officer of Project HOPE, to the OvaScience Board of Directors.

Similar Private Companies By Industry

Company Name Region
ABT Holding Co. United States
Hemera Biosciences Inc. United States
FirstString Research, Inc. United States
Tetracore, Inc. United States
BioResource International, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OvaScience, Inc., please visit www.ovascience.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.